Growth Metrics

TransMedics (TMDX) Deferred Taxes (2023 - 2026)

TransMedics' quarterly Deferred Taxes came in at $1.1 million in Q1 2026, up 989.17% quarter-over-quarter from -$120000.0 in Q4 2023.

TransMedics has reported Deferred Taxes for 2 years, with the latest figure at $1.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 TransMedics 2.32 Bn 1.86 Bn 101.16 Mn 1.07 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.07 Mn
Dec 31, 2023 -120,000.00